BRIEF—Insys execs guilty in opioid marketing case

Insys Therapeutics founder John Kapoor faces up to 20 years in prison after being convicted of bribing doctors to prescribe opioids in the USA.

Together with four colleagues, Mr Kapoor was found guilty of a racketeering conspiracy to bolster sales of the sublingual spray Subsys (fentanyl).

The federal court in Boston, Massachusetts, found that the executives ran a scheme to bribe doctors by paying them to speak at events held at restaurants, with the stated aim of promoting education around the product.